These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36942874)

  • 1. Creatinine Clearance May Predict Goal Enoxaparin Dose in Trauma.
    Park G; Dhillon NK; Fierro NM; Drevets P; Stupinski J; Ley EJ
    J Am Coll Surg; 2023 Jul; 237(1):94-100. PubMed ID: 36942874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creatinine clearance predicts the goal enoxaparin dose in traumatic brain injury.
    Park G; Dhillon NK; Fierro NM; Drevets P; Stupinski J; Ley EJ
    J Trauma Acute Care Surg; 2024 Feb; 96(2):270-275. PubMed ID: 37335174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics Associated With Higher Enoxaparin Dosing Requirements for Venous Thromboembolism Prophylaxis in Trauma Patients.
    Hashim YM; Dhillon NK; Veatch JM; Barmparas G; Ley EJ
    Am Surg; 2021 Jul; 87(7):1177-1181. PubMed ID: 33342267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
    Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
    JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which Trauma Patients Require Lower Enoxaparin Dosing for Venous Thromboembolism Prophylaxis?
    Veatch J; Hashim Y; Dhillon NK; Toscano S; Mason R; Lin TL; Barmparas G; Ley EJ
    Am Surg; 2020 Oct; 86(10):1424-1427. PubMed ID: 33155833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
    Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
    JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Evaluation of Weight-Based Prophylactic Enoxaparin Dosing in Critically Ill Trauma Patients: Adequacy of AntiXa Levels Is Improved.
    Nunez JM; Becher RD; Rebo GJ; Farrah JP; Borgerding EM; Stirparo JJ; Lauer C; Kilgo P; Miller PR
    Am Surg; 2015 Jun; 81(6):605-9. PubMed ID: 26031274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients.
    Costantini TW; Min E; Box K; Tran V; Winfield RD; Fortlage D; Doucet J; Bansal V; Coimbra R
    J Trauma Acute Care Surg; 2013 Jan; 74(1):128-33; discussion 134-5. PubMed ID: 23271087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achievement of goal anti-Xa activity with weight-based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients.
    Taylor A; Huang E; Waller J; White C; Martinez-Quinones P; Robinson T
    Pharmacotherapy; 2021 Jun; 41(6):508-514. PubMed ID: 33864688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trauma patients with lower extremity and pelvic fractures: Should anti-factor Xa trough level guide prophylactic enoxaparin dose?
    Dhillon NK; Smith EJT; Gillette E; Mason R; Barmparas G; Gewertz BL; Ley EJ
    Int J Surg; 2018 Mar; 51():128-132. PubMed ID: 29367044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients.
    Singer GA; Riggi G; Karcutskie CA; Vaghaiwalla TM; Lieberman HM; Ginzburg E; Namias N; Lineen EB
    J Trauma Acute Care Surg; 2016 Dec; 81(6):1101-1108. PubMed ID: 27488490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an enoxaparin dosing calculator using burn size and weight.
    Faraklas I; Ghanem M; Brown A; Cochran A
    J Burn Care Res; 2013; 34(6):621-7. PubMed ID: 24043245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Weight- and Anti-Xa-Guided Enoxaparin Dosing Protocol for venous thromboembolism Prophylaxis in intensive care unit Trauma Patients.
    Bigos R; Solomon E; Dorfman JD; Ha M
    J Surg Res; 2021 Sep; 265():122-130. PubMed ID: 33930618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative dosing of prophylactic enoxaparin in the trauma patient: is more the answer?
    Kopelman TR; O'Neill PJ; Pieri PG; Salomone JP; Hall ST; Quan A; Wells JR; Pressman MS
    Am J Surg; 2013 Dec; 206(6):911-5; discussion 915-6. PubMed ID: 24296098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Stratification for Supratherapeutic Peak Anti-Xa Levels in Adult Patients on Therapeutic Enoxaparin.
    Sheredy SA; Stone AC; Mostafavifar AM; Mostafavifar LG; Smith RM; Doepker BA
    Ann Pharmacother; 2024 Apr; 58(4):366-374. PubMed ID: 37515524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher doses of low-molecular-weight heparin (enoxaparin) are needed to achieve target anti-Xa concentrations in critically ill children*.
    Schloemer NJ; Abu-Sultaneh S; Hanson SJ; Yan K; Hoffmann RG; Punzalan RC; Havens PL
    Pediatr Crit Care Med; 2014 Sep; 15(7):e294-9. PubMed ID: 24901803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight-Based Dosing for Once-Daily Enoxaparin Cannot Provide Adequate Anticoagulation for Venous Thromboembolism Prophylaxis.
    Pannucci CJ; Hunt MM; Fleming KI; Prazak AM
    Plast Reconstr Surg; 2017 Oct; 140(4):815-822. PubMed ID: 28953735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One size does not fit all: Sex bias in pharmacologic venous thromboembolism prophylaxis.
    Modi RN; Borst JM; Kirchberg TN; Box K; Smith AM; Godat LN; Doucet JJ; Costantini TW; Berndtson AE
    J Trauma Acute Care Surg; 2023 Jan; 94(1):78-85. PubMed ID: 35787601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ATLANTIC study: Anti-Xa level assessment in trauma intensive care.
    Rakhra S; Martin EL; Fitzgerald M; Udy A
    Injury; 2020 Jan; 51(1):10-14. PubMed ID: 31679829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulation.
    Feng Y; Green B; Duffull SB; Kane-Gill SL; Bobek MB; Bies RR
    Br J Clin Pharmacol; 2006 Aug; 62(2):165-76. PubMed ID: 16842391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.